Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?
Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?作者机构：Department of Anesthesiology Heidelberg University Hospital Department of Internal Medicine I and Clinical Chemistry Heidelberg University Hospital
出 版 物：《World Journal of Experimental Medicine》 (世界实验医学杂志)
年 卷 期：2015年第5卷第2期
页 面：50-63页
学科分类：10[医学]
主 题：Clinical decision-making Biomarkers Early prediction Sepsis and mortality
摘 要：Beside many efforts to improve outcome, sepsis is still one of the most frequent causes of death in critically ill patients. It is the most common condition with high mortality in intensive care units. The complexity of the septic syndrome comprises immunological aspects- i.e.,sepsis induced immunosuppression- but is not restricted to this fact in modern concepts. So far, exact mechanisms and variables determining outcome and mortality stay unclear. Since there is no typical risk profile, early diagnosis and risk stratification remain difficult, which hinders rapid and effective treatment initiation. Due to the heterogeneous nature of sepsis, potential therapy options should be adapted to the individual. Biomarkers like C-reactive protein and procalcitonin are routinely used as complementary tools in clinical decision-making. Beyond the acute phase proteins, a wide bunch of promising substances and non-laboratory tools with potential diagnostic and prognostic value is under intensive investigation. So far, clinical decision just based on biomarker assessment is not yet feasible. However, biomarkers should be considered as a complementary approach.
维普期刊数据库